{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:48:07Z","timestamp":1761821287875},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6_suppl_1","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1212\/wnl.46.6_suppl_1.8s","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:20:56Z","timestamp":1336915256000},"update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":53,"title":["Parenteral antiepileptic\/anticonvulsant drugs"],"prefix":"10.1212","volume":"46","author":[{"given":"Richard H.","family":"Mattson","sequence":"first","affiliation":[{"name":"From the Department of Neurology, Yale University School of Medicine, New Haven, CT, and VA Connecticut."},{"name":"Address correspondence and reprint requests to Dr. Richard H. Mattson, Department of Neurology, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06510."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"Bialer M Cloy JD. General principles drug formulations and routes of administration. In: Levy RH Mattson RH Meldrum BS eds. Antiepileptic Drugs 4th ed. New York:Raven 1995."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380105"},{"key":"e_1_3_1_4_2","first-page":"2","volume":"38","year":"1988","unstructured":"Shaner DM, McCurdy SA, Herring MO, Gaber AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988;38:202-207.","journal-title":"Neurology"},{"key":"e_1_3_1_5_2","first-page":"1","volume":"1","year":"1969","unstructured":"Bell DS. Dangers of treatment of status epilepticus with diazepam. BMJ 1969;1:159-161.","journal-title":"BMJ"},{"key":"e_1_3_1_6_2","unstructured":"Painter MJ Gaus LM. Phenobarbital: clinical use. In: Levy RH Mattson RH Meldrum BS eds. Antiepileptic Drugs 4th ed. New York:Raven 1995."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1938.02790270003001"},{"key":"e_1_3_1_8_2","first-page":"3","volume":"38","year":"1981","unstructured":"Salem RB, Wilder BJ, Yosit RL, Doering PL, Lee C. Rapid infusion of phenytoin sodium loading doses. Am J Hosp Pharm 1981;38:354-357.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_1_9_2","first-page":"6","volume":"14","year":"1980","unstructured":"Salem RB, Yost RL, Torosian G, Davis FT. Investigation of the crystallization of phenytoin in normal saline. Drug Intell Clin Pharm 1980;14:605-608.","journal-title":"Drug Intell Clin Pharm"},{"key":"e_1_3_1_10_2","first-page":"5","volume":"36","year":"1979","unstructured":"Ramsay RE, Willmore LJ, Hammond EJ, Perchalski RJ, Wilder BJ. Brain uptake of phenytoin, phenobarbital, and diazepam. Arch Neurol 1979;36:535-539.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Ramsay RE. Pharmacokinetics and clinical use of parenteral phenytoin phenobarbital and paraldehyde. Epilepsia 1989;30(suppl 2):S1-S3.","DOI":"10.1111\/j.1528-1157.1989.tb05818.x"},{"key":"e_1_3_1_12_2","first-page":"5","volume":"1","year":"1977","unstructured":"Wilder BJ, Ramsay RE, Willmore LJ, et al. Efficacy of intravenous phenytoin in the treatment of status epilepticus: kinetics of central nervous system penetration. Ann Neurol 1977;1:511-518.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_13_2","unstructured":"Wilder BJ. Phenytoin: clinical use. In: Levy RH Mattson RH Meldrum BS eds. Antiepileptic Drugs 4th ed. New York: Raven 1995."},{"key":"e_1_3_1_14_2","first-page":"1","volume":"148","year":"1988","unstructured":"Spengier LRF, Arrowsmith JB, Kilarski DJ, Buchanan L, Von Behren L, Graham DR. Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors. Arch Intern Med 1988;148:1329-1333.","journal-title":"Arch Intern Med"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198407053110101"},{"key":"e_1_3_1_16_2","first-page":"9","volume":"68","year":"1988","unstructured":"Rao VK, Feldman PD, Dibbell DG. Extravasation injury to the hand by intravenous phenytoin: report of three cases. J Neurosurg 1988;68:967-969.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_17_2","first-page":"2","volume":"31","year":"1974","unstructured":"Wilder BJ, Serrano EE. Intramuscular administration of diphenylhydantoin: histologic follow-up studies. Arch Neurol 1974;31:276-278.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_18_2","first-page":"3","volume":"23","year":"1973","unstructured":"Serrano EE, Roye DB, Hammer RH, Wilder BJ. Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin. Neurology 1973;23:311-317.","journal-title":"Neurology"},{"key":"e_1_3_1_19_2","first-page":"5","volume":"16","year":"1974","unstructured":"Wilder BJ, Serrano EE, Ramsay RE, Buchanan RA. A method of shifting from oral to intramuscular diphenylhydantoin administration. Clin Pharm Ther 1974;16:507-513.","journal-title":"Clin Pharm Ther"},{"key":"e_1_3_1_20_2","first-page":"5","volume":"19","year":"1976","unstructured":"Wilder BJ, Ramsay RE. Oral and intramuscular phenytoin. Clin Pharmacol Ther 1976;19:564-573.","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198201073060101"},{"key":"e_1_3_1_22_2","first-page":"5","volume":"174","year":"1967","unstructured":"Louis S, Kutt H, McDowell F. The cardiocirculatory changes caused by intravenous dilantin and its solvent. Am Heart J 1967;174:523-529.","journal-title":"Am Heart J"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(67)90034-8"},{"key":"e_1_3_1_24_2","first-page":"7","volume":"249","year":"1983","unstructured":"Earnest MP, Marx JA, Drury LR. Complications of intravenous phenytoin for acute treatment of seizures. JAMA 1983;249:762-765.","journal-title":"JAMA"},{"key":"e_1_3_1_25_2","first-page":"2","volume":"74","year":"1942","unstructured":"Morris HJ, Nelson AA, Calvery HO. Observations on the chronic toxicities of propylene glycol, ethylene glycol, diethylene glycol, ethylene glycol, mono-ethyl-ether, diethylene glycol mono-ethyl ether. J Pharmacol Exp Ther 1942;74:266-273.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_26_2","first-page":"5","volume":"18","year":"1968","unstructured":"Wallis W, Kutt H, McDowell F. Intravenous diphenylhydantoin in treatment of acute repetitive seizures. Neurology 1968;18:513-525.","journal-title":"Neurology"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1982.tb05046.x"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb01590.x"},{"key":"e_1_3_1_29_2","first-page":"1","volume":"152","year":"1989","unstructured":"Price DJ. Intravenous valproate: experience in neurosurgery. Roy Soc Med Int Congr Symp Ser 1989;152:197-203.","journal-title":"Roy Soc Med Int Congr Symp Ser"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"3","year":"1961","unstructured":"Randall LO, Heise GA, Schallek W, et al. Pharmacological and clinical studies on valium. A new psychotherapeutic agent of the benzodiazepine class. Curr Ther Res 1961;3:405-425.","journal-title":"Curr Ther Res"},{"key":"e_1_3_1_31_2","first-page":"3","volume":"151","year":"1966","unstructured":"Swinyard WA, Castellion AW. Anticonvulsant properties of some benzodiazepines. J Pharmacol Exp Ther 1966;151:369-375.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_32_2","first-page":"2","volume":"5","year":"1967","unstructured":"Zbinden G, Randall LO. Pharmacology of benzodiazepines: laboratory and clinical correlations. Adv Pharmacol 1967;5:213-291.","journal-title":"Adv Pharmacol"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1965.tb03345.x"},{"key":"e_1_3_1_34_2","first-page":"4","volume":"18","year":"1965","unstructured":"Naquet R, Soulayrol R, Doce G, Tassinari CA, Broughton R, Loeb H. First attempt at treatment of experimental status epilepticus in animals and spontaneous status epilepticus in man with diazepam (valium). Electroencephalogr Clin Neurophysiol 1965;18:427.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"e_1_3_1_35_2","first-page":"5","volume":"12","year":"1970","unstructured":"Anticonvulsant drugs in idiopathic epilepsy. Med Lett Drugs Ther 1970;12:53-56.","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_3_1_36_2","first-page":"7","volume":"276","year":"1969","unstructured":"Prensky AL, Raff MD, Moore MJ, Schwab RS. Intravenous diazepam in the treatment of prolonged seizure activity. N Engl J Med 1969;276:779-784.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_37_2","first-page":"1","volume":"249","year":"1983","unstructured":"Leppik IE, Derivan AT, Homan RW, et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-1454.","journal-title":"JAMA"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1968.03140010075040"},{"key":"e_1_3_1_39_2","unstructured":"Treiman DM. The role of benzodiazepines in the management of status epilepticus. Neurology 1990;40(Suppl 2):32-42."},{"key":"e_1_3_1_40_2","first-page":"3","volume":"38","year":"1988","unstructured":"Lowenstein DH, Aminoff MJ, Simon RP. Barbiturate anesthesia in the treatment of refractory status epilepticus. Neurology 1988;38:395-400.","journal-title":"Neurology"},{"key":"e_1_3_1_41_2","first-page":"5","volume":"37","year":"1987","unstructured":"Rashkin MC, Youngs C, Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology 1987;37:500-503.","journal-title":"Neurology"},{"key":"e_1_3_1_42_2","first-page":"8","volume":"270","year":"1993","unstructured":"Working Group on Status Epilepticus. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993;270:854-850.","journal-title":"JAMA"},{"key":"e_1_3_1_43_2","first-page":"1","volume":"369","year":"1995","unstructured":"Kuisma M, Rione RO. Propofol in prehospital treatment of convulsive status epilepticus. Epilepsia 1995;369:1241-1243.","journal-title":"Epilepsia"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.46.6_Suppl_1.8S","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:33:06Z","timestamp":1711546386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.46.6_Suppl_1.8S"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":42,"journal-issue":{"issue":"6_suppl_1","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["10.1212\/WNL.46.6_Suppl_1.8S"],"URL":"https:\/\/doi.org\/10.1212\/wnl.46.6_suppl_1.8s","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}